Tight controlled dose reduction of biologics in psoriasis patients7 May 2020
Published in JAMA Dermatology, RIHS researcher Selma Atalay and colleagues investigated in a randomized controlled trial a tight controlled dose reduction strategy of the biologics adalimumab, etanercept and ustekinumab in psoriasis patients.
In order to maximize quality of life in pediatric psoriasis reaching for clear skin is necessary12 December 2019
In JAMA Dermatology, Bruins et al showed that greatest improvement in quality of life was achieved with 90% improvement of the Psoriasis Area and Severity Index (PASI) and 90% decrease of affected body surface area in a large cohort of children with psoriasis.
LEO Foundation grant for Ellen van den Bogaard and Patrick Zeeuwen17 January 2019
LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide that improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms.
A personal touch of Carine van der Vleuten20 September 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Carine van der Vleuten.
Carine van der Vleuten appointed associate Professor Vascular anomalies28 February 2018
As associate Professor with a research accent, she will focus her research on vascular anomalies, particularly on propranolol treatment of infantile hemangioma and also on Klippel-Trenaunay Syndrome and other somatic over-growth syndromes (SOGS).